InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Marco Maria Brughera
15 Sep 2026
Director
Sold after exercise
15,545
$10.29
$159.96K
Rosty Raykov
1 Jul 2026
Former Director
Sold after exercise
9,599
$10.41
$99.93K
Rosty Raykov
1 Jun 2026
Director
Sold after exercise
9,747
$9.62
$93.77K
Chris A Rallis
11 May 2026
Director
Sold after exercise
8,346
$7.04
$58.76K
Rosty Raykov
1 May 2026
Director
Sold after exercise
10,781
$6.47
$69.75K
Rosty Raykov
1 Apr 2026
Director
Sold after exercise
10,946
$6.31
$69.07K
Rosty Raykov
2 Mar 2026
Director
Sold after exercise
10,079
$8.36
$84.26K
Rosty Raykov
2 Feb 2026
Director
Sold after exercise
10,349
$7.76
$80.31K
Rosty Raykov
2 Jan 2026
Director
Sold after exercise
10,312
$7.60
$78.37K
Show all 25 transactions →

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 464,085
History held since 2 May 2007